These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8510694)

  • 21. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in the susceptibility of tuberculosis in New York City, 1987-1991. New York City Area Tuberculosis Working Group.
    Sepkowitz KA; Telzak EE; Recalde S; Armstrong D
    Clin Infect Dis; 1994 May; 18(5):755-9. PubMed ID: 8075265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.
    Bifani P; Mathema B; Kurepina N; Shashkina E; Bertout J; Blanchis AS; Moghazeh S; Driscoll J; Gicquel B; Frothingham R; Kreiswirth BN
    J Infect Dis; 2008 Jul; 198(1):90-4. PubMed ID: 18498237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tuberculosis--current therapeutic concepts].
    Grünhage F; Sauerbruch T; Spengler U
    Dtsch Med Wochenschr; 2005 Jan; 130(4):159-64. PubMed ID: 15662583
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tuberculosis in the 21st centruy].
    Casal M
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):207-8. PubMed ID: 10974762
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary anti-tuberculosis drugs. II: resistant typical mycobacterium tuberculosis, unclassified mycobacteria.
    J Kans Med Soc; 1968 Nov; 69(11):534-6 concl. PubMed ID: 4972834
    [No Abstract]   [Full Text] [Related]  

  • 30. Comment on "Thwaites et al., 2005, The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis" J Infect Dis. 2005 Dec 15;192(12):2134-41.
    Dhasmana DJ; Davidson RN
    J Infect; 2007 Feb; 54(2):205; author reply 206. PubMed ID: 16887190
    [No Abstract]   [Full Text] [Related]  

  • 31. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates].
    Zhukova MP
    Probl Tuberk; 1998; (4):4-5. PubMed ID: 9771024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City.
    Driver CR; Munsiff SS; Li J; Kundamal N; Osahan SS
    Clin Infect Dis; 2001 Nov; 33(10):1762-9. PubMed ID: 11595988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rising standards for tuberculosis drug development.
    Balganesh TS; Alzari PM; Cole ST
    Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant tuberculosis.
    Dooley SW; Jarvis WR; Martone WJ; Snider DE
    Ann Intern Med; 1992 Aug; 117(3):257-9. PubMed ID: 1296597
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistant Mycobacterium tuberculosis in Saudi Arabia.
    Arya SC
    Saudi Med J; 2002 Apr; 23(4):475. PubMed ID: 11953781
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular determinants of drug resistance in tuberculosis.
    Riska PF; Jacobs WR; Alland D
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S4-10. PubMed ID: 10688142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis.
    Shamaei M; Marjani M; Baghaei P; Chitsaz E; Rezaei Tabar E; Abrishami Z; Tabarsi P; Mansouri D; Masjedi MR
    Int J STD AIDS; 2009 May; 20(5):320-3. PubMed ID: 19386968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.